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Polyimide is commonly used for packaging of medical devices due to its thermal and chemical stability, mechanical strength and
flexibility and low moisture absorption [1]. Although it is known to be biocompatible [2], a cold plasma treatment has been applied
for the activation of BPDA-PPD polyimide in order to enhance the interaction and integration of the device with the surrounding
tissue to minimize the foreign body reaction after implantation. The influence of different parameters of the plasma activation on
the surface composition of polyimide has been studied (exposure time, discharge power, plasma gas) as well as the hydrophobic
recovery of optimal treatments over the 24 h following the exposure. For all gases (air, He, N2, Ar) short treatment times (1.0-32.0
s) and low discharge powers (1.5-3.0 W) revealed to be enough to introduce oxygen-containing functional groups, with an increase
of 40-70% in the O/C ratio. Hydrophobic recovery stabilized fast (2.0-4.0 h after exposure) although the functionalities introduced
onto the surface were not significantly affected. Eventually, it was confirmed that air or nitrogen plasma activation of polyimide can
substantially increase fibroblasts attachment and viability, showing the potential of cold plasma treatment to improve the interaction
of polyimide with the body tissue.
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